About the Editors

Editor-in-Chief

Sunil Nadar, MD, FESC, Dudley group of hospitals NHS trust UK, UK

Dr Sunil Nadar is a consultant interventional cardiologist at the Dudley group of hospitals NHS trust UK, having worked previously at Sultan Qaboos University Hospital, Muscat, Oman and the Heart of England NHS trust as a consultant cardiologist and  an honorary senior lecturer with the University of Birmingham UK. During his time in Oman he was listed on google scholar as one of the top ten researchers in Oman in 2016. He had completed his postgraduate research with Professor Gregory Lip and Professor Gareth Beevers at the University of Birmingham UK, on hypertension and platelet function and has co-edited a book on Hypertension with Prof Lip. His main research interests are  platelet activation, hypertension, coronary artery disease, and coronary intervention. He is a fellow of the Royal college of physicians London and a Fellow of the European Society of cardiology. 

Associate Editors

Fadi Charchar, PhD, FAHA, Federation University, Australia

Professor Fadi Charchar is the Robert HT Smith Chair in Cardiovascular Genomics and Dean, Graduate Research School at Federation University. Professorial Research Fellow at the University of Melbourne and Visiting Chair at University of Leicester, UK. Professor Charchar is the Vice-President of the International Society of Hypertension and President of the International Society of Heart Research. He previously completed a Wellcome Trust Fellowship and a British Heart Foundation Lectureship in the UK.  He is an internationally recognized expert in understanding the genetic mechanisms of cardiovascular disease. His research includes findings that the human Y chromosome contributes to hypertension and CAD.

Christian Delles, MD, FRCP, FAHA, FBIHS, University of Glasgow, UK

Christian Delles is Professor of Cardiovascular Prevention and Deputy Director of the Institute for Cardiovascular and Medical Sciences, University of Glasgow; and Honorary Consultant Physician with NHS Greater Glasgow & Clyde. His research is in the area of vascular biology with oxidative stress and endothelial function as pathogenetic factors of hypertension and other cardiovascular disorders. As such he studies markers for early diagnosis of a wide range of conditions including diabetic nephropathy; the molecular basis of vascular and renal diseases; the pathogenesis and long-term consequences of hypertensive disorders of pregnancy and gestational diabetes; and differences in the pathophysiology of cardiovascular diseases between men and women. Christian serves as Treasurer of the British and Irish Hypertension Society and Honorary Secretary of the Association of Physicians of Great Britain and Ireland. He is a member of national and international grant panels, associate editor and member of the editorial board of leading cardiovascular journals and has published more than 230 peer reviewed papers.

Catherine Derington, PharmD, MS, University of Colorado School of Medicine, USA

Dr Catherine Derington is faculty member at the University of Colorado School of Medicine, an Investigator at the Adult & Child Center for Outcomes Research & Delivery Science, and researcher with the Veterans Affairs health system. Leverages her clinical pharmacist expertise, she focuses on optimizing cardiovascular medications to manage and prevent hypertension-related complications. Using large datasets and pharmacoepidemiologic methods, her research examines treatment effects on patient-centered outcomes and assesses the impact of medication prescribing, dispensing, and adherence patterns on care.

Federica Piani, MD, PhD, Medical University of Graz, Austria

Federica Piani, MD, PhD, is a clinician scientist and Tenure-Track Assistant Professor of Physiology and Pathophysiology at the Medical University of Graz, Austria. Her research focuses on integrative and translational human hemodynamics, with particular interest in the regulation of blood pressure and vascular function under physiological and pathological stress. She investigates the interactions between cardiac, vascular, autonomic, and metabolic systems using advanced hemodynamic phenotyping, continuous monitoring, and multimodal vascular imaging to characterize early target organ involvement and subclinical vascular dysfunction. Her work further integrates molecular and proteomic approaches targeting endothelial pathways, including the endothelial glycocalyx, to link systemic hemodynamic regulation with mechanisms of vascular injury and repair. A major translational focus of her research is female cardiovascular adaptation, with pregnancy studied as a model of cardiovascular stress to understand sex-specific vulnerability and the early pathogenesis of hypertensive and cardiometabolic disease.

Kalpana Sabapathy, PhD, London School of Hygiene and Tropical Medicine, UK

Kalpana Sabapathy is a clinical epidemiologist and Associate Professor at LSHTM. She is a Wellcome Trust fellow and PI on the SHEAR Zim (Significance of Hypertension in Early Adulthood Research in Zimbabwe) study. Kalpana has 20 years’ experience of working in southern Africa and recently led a study examining community approaches to improving detection and monitoring of high blood pressure in Zimbabwe, funded by the UK Medical Research Council. Before that, she was an investigator on the landmark HPTN 071 (PopART) trial in Zambia and South Africa, and previously worked with Medecins Sans Frontieres for six years in several settings. Kalpana also maintains clinical practice as a part-time GP in the NHS, in the UK.

Pantelis Sarafidis, MD, MSc, PhD, Aristotle University of Thessaloniki, Greece

Dr Sarafidis, MD, MSc, PhD is an Associate Professor in Nephrology at Aristotle University of Thessaloniki, and Consultant in Nephrology in Hippokration Hospita. He is the Head of the ESH Hypertension Excellence Center in this hospital. He received his MD degree from Aristotle University of Thessaloniki and a MSc in Health Units Administration from Hellenic Open University. Dr Sarafidis completed his training in Nephrology in the 1^st Department of Medicine, AHEPA Hospital, where he also completed his PhD thesis on the relationship of Metabolic Syndrome with Hypertension and Kidney Disease between 2001-2005. He completed two yearly post-doc fellowships in the Hypertension/Clinical Research Center, Rush University Medical Center, Chicago and the Department of Renal Medicine, King's College Hospital, London. In 2008 he received the title ESH Clinical Hypertension Specialist. During the past 18 years, the clinical and research activities of Dr Sarafidis have been focused on hypertension, diabetic and hypertensive nephropathy, acute kidney injury, anemia in CKD, polycystic kidney disease and CVD in ESRD patients. He has participated as principal or sub-investigator in numerous observational studies and clinical trials in the above fields. He has authored more than 240 articles in peer-reviewed international medical journals and book chapters in international textbooks, and performed more than 200 lectures in national and international meetings in the areas of Nephrology, Hypertension and related fields. He is currently a reviewer for more than 60 international medical journals and serves on the Editorial Board of five. Dr Sarafidis has received several awards and grants from national and international Medical Societies for his research activities.

Martin Schultz, PhD, AEP, Menzies Institute for Medical Research, University of Tasmania, Australia

A/Prof Martin Schultz is a Principal Research Fellow at the Menzies Institute for Medical Research, University of Tasmania. He is an Accredited Exercise Physiologist (AEP) and undertakes research in the area of clinical cardiovascular physiology with a focus on exercise and its role in the identification of cardiovascular risk. A/Prof Schultz's research program has been focused on building key evidence and data that supports the role of exercise in the prevention, detection and management of high BP, with particular emphasis on measuring BP during clinical exercise testing. He has recently led a large national collaboration (the EXERcise stress Test collaboratION, the 'EXERTION' study) linking exercise BP to CVD outcomes, highlighting the important role of considering cardiorespiratory fitness for clinical interpretation exercise BP, along with publication of key clinical considerations for the measurement of exercise BP, and care pathways for the exercise professions to take an active role in the identification and management of high BP. A/Prof Schultz has published >100 scientific papers and been awarded >$3 million in competitive research grants and fellowships

Jun Yang, MBBS, FRACP, PhD, Hudson Institute of Medical Research, Australia

Associate Professor Jun Yang is the Head of the Endocrine Hypertension Group at Hudson Institute of Medical Research, a Consultant Endocrinologist at Monash Health, and a Senior Researcher in the Department of Medicine at Monash University, Victoria, Australia. Jun graduated from Monash University with a MBBS (Hon) in 2001, attained her FRACP in 2010, and completed a PhD in 2013 focusing on tissue-selective coregulators of the mineralocorticoid receptor (MR). She has since advanced basic and clinical research in the field of MR-driven cardiovascular disease, particularly primary aldosteronism, contributing to 150 original publications.  She established Victoria’s first Endocrine Hypertension Service, co-leads the Primary Aldosteronism Centre of Excellence, and enjoys fostering national and international collaborations to enhance the detection and management of primary aldosteronism for better patient outcomes.

Yuichiro Yano, MD, Duke University School of Medicine, USA

Yuichiro Yano, MD, PhD, is Assistant Professor at the Duke University School of Medicine. As a physician scientist he has been conducting prospective observational and interventional studies using clinic, home, and 24-hour ambulatory blood pressure monitoring in Japan and the U.S. He has also been conducting research on the etiology and outcomes of abnormal blood pressure phenotypes, longitudinal modeling of cardiovascular risks, and cardiovascular disease risk prediction among young adults. He has authored or co-authored more than 100 publications in peer reviewed journals in the field, including Journal of the American Medical Association (JAMA). In 2016 he received the American Society of Hypertension’s Young Scholar Award and the Sandra A. Daugherty Award from the American Heart Association. In 2017 he received the Hypertension Top Paper Award. He was recently recognized by the American Heart Association for authoring one of the most impactful publications of 2018, and received Japanese Society of Hypertension Academic Award 2019.

BIHS Representative

Dr Sarah Partridge, BN, MSc, PhD, University of Sussex, Brighton, UK